US Patent No: 4,277,582

Number of patents in Portfolio can not be more than 2000

Water-insoluble hydrophilic copolymers

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A water-insoluble hydrophilic gel comprising: (A) about 30 to about 90% of a hydrophilic (a) polymer of identical or different watersoluble mono-olefinic monomers, or (b) copolymer of said watersoluble monomers with 1 to 70% of water-insoluble, identical or different mono-olefinic monomers, which polymer or copolymer is cross-linked with (B) about 10 to about 70% of a terminal diolefinic hydrophobic macromer having a molecular weight from about 400 to about 8000.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
CIBA SPECIALTY CHEMICALS CORPORATIONTARRYTOWN, NY946

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Good, William R Salt Lake City, UT 8 329
Mueller, Karl F New York, NY 53 1806

Cited Art Landscape

  • No Cited Art to Display

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (9)
* 5,709,854 Tissue formation by injecting a cell-polymeric solution that gels in vivo 183 1993
* 5,567,612 Genitourinary cell-matrix structure for implantation into a human and a method of making 60 1993
* 5,804,178 Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue 51 1994
* 5,759,830 Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo 96 1994
6,309,635 Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo 11 1994
* 5,716,404 Breast tissue engineering 154 1994
6,840,962 Tissue engineered tendons and ligaments 51 2000
7,807,150 Injectable composition containing crosslinkable material and cells for forming animal tissue 1 2004
7,914,579 Tissue engineered tendons and ligaments 0 2006
 
THE CLEVELAND CLINIC FOUNDATION (9)
6,982,298 Hydroxyphenyl cross-linked macromolecular network and applications thereof 14 2004
7,465,766 Hydroxyphenyl cross-linked macromolecular network and applications thereof 3 2005
7,368,502 Hydroxyphenyl cross-linked macromolecular network and applications thereof 3 2005
8,207,262 Hydroxyphenyl cross-linked macromolecular network and applications thereof 1 2008
8,138,265 Hydroxyphenyl cross-linked macromolecular network and applications thereof 3 2009
8,021,350 Hydroxyphenyl cross-linked macromolecular network and applications thereof 1 2009
8,080,260 Molecular enhancement of extracellular matrix and methods of use 1 2009
8,137,688 Hydroxyphenyl cross-linked macromolecular network and applications thereof 2 2009
8,410,180 Methods to treat urinary incontinence 0 2009
 
CHILDREN'S MEDICAL CENTER CORPORATION (5)
* 5,741,685 Parenchymal cells packaged in immunoprotective tissue for implantation 24 1995
* 5,851,833 Neomorphogenesis of urological structures in vivo from cell culture 19 1996
6,348,069 Engineering of strong, pliable tissues 31 1998
RE42479 Engineering of strong, pliable tissues 0 2004
RE42575 Engineering of strong, pliable tissues 0 2006
 
DSM RESINS BV (4)
* 4,582,883 Compositions containing maleimide-amide compounds as well as the preparation and application thereof 5 1984
* 4,684,706 Compositions containing maleimide-amide compounds as well as the preparation and application thereof 1 1986
* 4,782,133 Method for preparing compositions containing maleimide-amide compounds 1 1987
* 5,075,398 Bismaleimide-styrene compound-acid compound-containing thermosetting composition 3 1989
 
DYNAGEN, INC. (3)
* 5,403,595 Controlled, sustained release delivery system for smoking cessation 29 1993
* 5,486,362 Controlled, sustained release delivery system for treating drug dependency 94 1993
* 5,780,051 Methods and articles of manufacture for nicotine cessation and monitoring nicotine use 34 1997
 
Bausch & Lomb Incorporated (2)
* 5,352,714 Wettable silicone hydrogel compositions and methods for their manufacture 69 1992
* 5,451,617 Wettable silicone hydrogel compositions and methods for their manufacture 90 1993
 
CALIFORNIA INSTITUTE OF TECHNOLOGY (2)
* 5,290,411 Acrylic polymer electrophoresis support media 6 1993
* 5,397,449 Acrylic polymer electrophoresis support media 8 1994
 
CORNELL UNIVERSITY (2)
* 6,583,219 Hydrogel-forming system with hydrophobic and hydrophilic components 17 2002
6,709,668 Hydrogel-forming system with hydrophobic and hydrophilic components 20 2003
 
Massachusetts Institute of Technology Children's Medical Center Corporation (2)
* 5,770,193 Preparation of three-dimensional fibrous scaffold for attaching cells to produce vascularized tissue in vivo 90 1994
* 5,770,417 Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo 120 1994
 
NOVARTIS;CORPORATE INTELLECTUAL PROPERTY (2)
* 5,532,287 Radiation cured drug release controlling membrane 0 1994
* 5,545,442 Method for using a radiation cured drug release controlling membrane 1 1995
 
The Dow Chemical Company (2)
* 4,431,498 Radiation curable water-miscible compositions of vinyl ester resins 3 1980
* 4,505,827 Triblock polymers of the BAB type having hydrophobic association capabilities for rheological control in aqueous systems 19 1983
 
ACCESS PHARMACEUTICALS, INC. (1)
6,521,431 Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments 17 1999
 
ALLIED COLLOIDS LIMITED (1)
* 4,980,434 Absorbent polymers, their manufacture and uses 14 1988
 
ALZA CORPORATION (1)
8,084,059 Antidepressant dosage form 0 2006
 
BRITISH TECHNOLOGY GROUP LIMITED (1)
* 4,542,176 Preparation of particulate gels 26 1984
 
GENERAL ELECTRIC COMPANY (1)
* 4,609,705 Polyimide molding compositions 7 1985
 
HUNTSMAN PETROCHEMCIAL CORPORATION (1)
* 4,826,995 Bismaleimide derivatives of higher molecular weight polyoxyalkyleneamines 13 1987
 
ISP CAPITAL, INC. (1)
* 5,464,627 Extrudible wet paste composition of an agriculturally active chemical; free-flowing, water-dispersible or water-soluble granules therefrom 4 1993
 
KIMBERLY-CLARK WORLDWIDE, INC. (1)
* 5,082,723 Osmotically enhanced absorbent structures 23 1989
 
NOVARTIS AG (1)
* 4,711,943 Hydrophilic siloxane monomers and dimers for contact lens materials, and contact lenses fabricated therefrom 110 1985
 
REPROGENESIS, INC. (1)
* 6,129,761 Injectable hydrogel compositions 454 1995
 
Seitetsu Kagaku Co., Ltd. (1)
* 4,590,227 Water-swellable elastomer composition 131 1984
 
SHOWA DENKO K.K. (1)
* 4,351,922 Process for the production of highly water-absorbing but less water-soluble hydrogels 38 1980
 
The Kendall Company (1)
* 4,693,887 Microphase separated hydrogels for controlled release of bioactive materials 34 1984
 
VSESOJUZNY NAUCHNO-ISSLEDOVATELSKY I ISPYTATELNY INSTITUT MEDITSINSKOI TEKHNIKI (1)
* 4,875,479 Sutural material 12 1988
* Cited By Examiner